Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

SHA:688319 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,104	4,303	6,417	5,621	14,513	-
Market Cap Growth	72.14%	-32.95%	14.17%	-61.27%	-	-
Enterprise Value	7,278	4,422	6,267	5,420	14,115	-
Last Close Price	17.50	10.60	15.74	13.81	35.67	-
PE Ratio	178.91	207.29	365.54	211.50	134.42	-
Forward PE	-	98.61	60.77	38.44	59.68	-
PS Ratio	11.73	7.31	12.94	10.27	29.79	-
PB Ratio	7.65	4.61	6.90	6.30	17.18	-
P/TBV Ratio	7.86	4.74	7.13	6.51	17.47	-
P/OCF Ratio	220.90	-	145.85	-	363.16	-
EV/Sales Ratio	12.02	7.51	12.63	9.90	28.97	-
EV/EBITDA Ratio	94.98	89.21	204.71	135.49	120.71	-
EV/EBIT Ratio	162.57	204.54	1787.91	368.70	150.33	-
Debt / Equity Ratio	0.41	0.39	0.26	0.15	0.05	0.07
Debt / EBITDA Ratio	4.96	6.79	6.93	3.35	0.33	0.60
Asset Turnover	0.36	0.34	0.32	0.41	0.53	0.57
Inventory Turnover	0.37	0.38	0.49	0.56	0.47	0.45
Quick Ratio	1.43	1.37	1.80	1.63	2.34	1.28
Current Ratio	1.61	1.53	1.96	1.78	2.56	1.51
Return on Equity (ROE)	3.92%	1.69%	1.26%	3.06%	17.68%	10.07%
Return on Assets (ROA)	1.66%	0.79%	0.14%	0.68%	6.33%	3.10%
Return on Capital (ROIC)	2.22%	1.10%	0.20%	0.96%	9.12%	4.63%
Return on Capital Employed (ROCE)	3.60%	1.80%	0.30%	1.50%	10.80%	7.00%
Earnings Yield	0.56%	0.48%	0.27%	0.47%	0.74%	-
FCF Yield	-2.19%	-5.04%	-1.96%	-4.01%	-0.21%	-
Dividend Yield	-	-	0.24%	-	-	-
Payout Ratio	77.21%	142.97%	34.11%	16.00%	0.95%	-
Buyback Yield / Dilution	-0.06%	0.01%	-0.07%	-5.22%	-5.61%	-0.89%
Total Shareholder Return	-	0.01%	0.17%	-5.22%	-5.61%	-0.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.